Dissemin is shutting down on January 1st, 2025

Published in

Karger Publishers, Oncology Research and Treatment, 5(42), p. 263-268, 2019

DOI: 10.1159/000497209

Links

Tools

Export citation

Search in Google Scholar

Genetic Variant Screening of DNA Repair Genes in Myelodysplastic Syndrome Identifies a Novel Mutation in the <b>XRCC2</b> Gene

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

<b><i>Background:</i></b> We aimed to detect single nucleotide polymorphisms (SNPs) and mutations in DNA repair genes and their possible association with myelodysplastic syndrome (MDS). <b><i>Methods:</i></b> Targeted enrichment resequencing of 84 DNA repair genes was initially performed on a screening cohort of MDS patients. Real-time polymerase chain reaction was used for genotyping selected SNPs in the validation cohort of patients. <b><i>Results:</i></b> A heterozygous frameshift mutation in the <i>XRCC2</i> gene was identified. It leads to the formation of a truncated non-functional protein and decreased <i>XRCC2</i> expression level. Decreased expression levels of all DNA repair genes functionally connected with mutated <i>XRCC2</i> were also present. Moreover, a synonymous substitution in the <i>PRKDC</i> gene<i></i> and 2 missense mutations in the <i>SMUG1</i> and <i>XRCC1</i> genes were also found. In the screening cohort, 6 candidate SNPs were associated with the tendency to develop MDS: rs4135113 (TDG, p = 0.03), rs12917 (MGMT, p = 0.003), rs2230641 (CCNH, p = 0.01), rs2228529 and rs2228526 (ERCC6, p = 0.04 and p = 0.03), and rs1799977 (MLH1, p = 0.04). In the validation cohort, only a polymorphism in <i>MLH1</i> was significantly associated with development of MDS in patients with poor cytogenetics (p = 0.0004). <b><i>Conclusion:</i></b> Our study demonstrates that genetic variants are present in DNA repair genes of MDS patients and may be associated with susceptibility to MDS.